Latest Breaking News On - Astrazeneca pharma india - Page 1 : comparemela.com

Astrazeneca Pharma India Q4 Results Live : profit rise by 128.61% YOY

Astrazeneca Pharma India Q4 Results Live : Revenue increased by 34.6% YoY & profit increased by 128.61% YoY

Stocks in news: LIC, Tata Steel, NTPC, Hero Moto, Divis Labs, RVNL, Auro Pharma and DOMS

LIC, NMDC, Nalco, Sumitomo Chemicals, Elgi Equipments, NMDC Steel, Natco Pharma, GMDC, TVS Supply Chain Solutions, MSTC and more will announce their quarterly results today.

Pharma stocks in focus; Astrazeneca, Glenmark, Divi's, Torrent soar upto 9%

AstraZeneca: India's drug regulator orders withdrawal of AstraZeneca's cancer drug due to potential adverse effects |

DCGI orders withdrawal of AstraZeneca's Olaparib tablets for gBRCA mutation and advanced ovarian cancer due to potential adverse effects. The drug was

DCGI orders withdrawal of cancer drug Olaparib for certain treatments

The communication stated that the firm presented the clinical evidence for the withdrawal of indication of Olaparib tablets.